SCHEMBL30684534

SCHEMBL30684534

O=C(O)N1CCC(N2CC(C(F)(F)F)NC2=O)CC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17977057 0.77 KMT2A (0.34) —
SCHEMBL17977074 0.73 ALOX5 (0.35) —
SCHEMBL27670262 0.71 ACHE (0.32) —
SCHEMBL27037022 0.70 — —
SCHEMBL17977094 0.68 TGM2 (0.44) CALCRL
SCHEMBL16530402 0.67 KMT2A (0.38) —
SCHEMBL1814278 0.67 CALCRL (0.37) CALCRL
SCHEMBL2825842 0.66 SPR (0.39) —
SCHEMBL27689313 0.66 CDA (0.38) CALCRL
SCHEMBL9057675 0.66 F10 (0.45) CALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558223-A1 IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2025-05-28 — — EP disclosed
WO-2024017880-A1 IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS UCB Biopharma SRL (BE) 2024-01-25 — — WO disclosed
Send feedback